Preoperative Bevacizumab in Combination With Paclitaxel and Carboplatin in Surgically Resectable Non-Small Cell Lung Cancer

被引：3
|
作者：
Bertino, Erin [1 ]
Villalona-Calero, Miguel A. [1 ]
Ross, Patrick [2 ]
Grever, Michael [3 ]
Otterson, Gregory A. [3 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
来源：
ANNALS OF THORACIC SURGERY | 2011年 / 91卷 / 02期
关键词：
TRIAL; SURGERY; CHEMOTHERAPY;
D O I：
10.1016/j.athoracsur.2010.07.047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：640 / 640
页数：1
相关论文
共 50 条
  • [41] Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients
    de Goeje, Pauline L.
    Poncin, Myrthe
    Bezemer, Koen
    Kaijen-Lambers, Margaretha E. H.
    Groen, Harry J. M.
    Smit, Egbert F.
    Dingemans, Anne-Marie C.
    Kunert, Andre
    Hendriks, Rudi W.
    Aerts, Joachim G. J. V.
    CLINICAL CANCER RESEARCH, 2019, 25 (07) : 2219 - 2227
  • [42] Paclitaxel, gemcitabin, and cisplatin in non-resectable non-small cell lung cancer (NSCLC)
    Sorensen, JB
    Stenbygaard, LE
    Hansen, HH
    Osterlind, K
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S258 - S258
  • [43] Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non-Small-Cell Lung Cancer
    Soria, Jean-Charles
    Mark, Zsuzsanna
    Zatloukal, Petr
    Szima, Barna
    Albert, Istvan
    Juhasz, Erzsebet
    Pujol, Jean-Louis
    Kozielski, Jerzy
    Baker, Nigel
    Smethurst, Dominic
    Hei, Yong-jiang
    Ashkenazi, Avi
    Stern, Howard
    Amler, Lukas
    Pan, Yang
    Blackhall, Fiona
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) : 4442 - 4451
  • [44] Bevacizumab in Non-Small Cell Lung Cancer
    Francesco Di Costanzo
    Francesca Mazzoni
    Marinella Micol Mela
    Lorenzo Antonuzzo
    Daniele Checcacci
    Matilde Saggese
    Federica Di Costanzo
    Drugs, 2008, 68 : 737 - 746
  • [45] Bevacizumab in non-small cell lung cancer
    Di Costanzo, Francesco
    Mazzoni, Francesca
    Mela, Marinella Micol
    Antonuzzo, Lorenzo
    Checcacci, Daniele
    Saggese, Matilde
    Di Costanzo, Federica
    DRUGS, 2008, 68 (06) : 737 - 746
  • [46] Bevacizumab plus Weekly Paclitaxel with or Without Carboplatin for Previously-treated Non-squamous Non-Small Cell Lung Cancer
    Hata, Akito
    Katakami, Nobuyuki
    Tanaka, Kosuke
    Takeshita, Jumpei
    Matsumoto, Takeshi
    Monden, Kazuya
    Nagata, Kazuma
    Masago, Katsuhiro
    Kaji, Reiko
    Fujita, Shiro
    Tachikawa, Ryo
    Otsuka, Kyoko
    Otsuka, Kojiro
    Tomii, Keisuke
    ANTICANCER RESEARCH, 2014, 34 (1A) : 275 - 281
  • [47] Bevacizumab in non-small cell lung cancer
    Sandler, Alan
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4613S - 4616S
  • [48] Carboplatin and paclitaxel (Taxol®) for non-small cell lung cancer [NSCLC], a standard regimen?
    Pralong-Kohler, J
    Stupp, R
    Monnerat, C
    Bauer, J
    Stalder, M
    Perey, L
    Leyvraz, S
    ANNALS OF ONCOLOGY, 1998, 9 : 87 - 87
  • [49] Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells
    Owonikoko, Taofeek K.
    Ramalingam, Suresh S.
    Kanterewicz, Beatriz
    Balius, Trent E.
    Belani, Chandra P.
    Hershberger, Pamela A.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (03) : 743 - 755
  • [50] High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer
    Socinski, MA
    Shea, TC
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 45 - 51
12345